Table 1.

Key recommendations from the JBS3 risk calculator tool

The risk calculator is not appropriate for diabetic patients aged over 40 years, those with CKD Stages 3–5 or those with FH

A non-fasting blood sample should be used for lipid profile estimation, measuring total cholesterol and HDL cholesterol

Non-HDL cholesterol should be used in preference to LDL cholesterol as the treatment goal for lipid-lowering therapy

Non-HDL cholesterol is based on non-fasting total cholesterol minus HDL cholesterol

Patients with existing CVD require intensive risk factor modification with diet, lifestyle and drug therapy, without the need for estimation of future risk This also applies to those with diabetes older than 40 years and those with CKD Stages 3–5 or FH

Clear lifestyle guidance is provided on a healthy diet and physical activity, with support for an increase in exercise on referral and community-based exercise initiatives

All healthcare professionals should be able to Ask and Assess adiposity and Advise (The 3 As) appropriate adult patients on evidence-based ways to lose weight

The lipid recommendations endorse the use of non-HDL cholesterol and all high-risk patients should receive professional lifestyle support to reduce total cholesterol, raise HDL cholesterol and lower triglycerides

CKD chronic kidney disease, FH familial hypercholesterolaemia, HDL high-density lipoprotein, LDL low-density lipoprotein